Beyond Weight Loss, Limited Bariatric Surgery Benefits in Older AdultsSeptember 12, 2024GastroenterologyPreventive CareASCO Breast CancerGenitourinary Cancer
Outcomes with CDK4/6 Inhibitors Vary in BCJuly 30, 2024Breast CancerPatient & Survivor CareASCO Breast Cancer
Black Women With Breast Cancer Face Clinical InequitiesJuly 26, 2024ASCO Breast CancerBreast CancerDiversity in Medicine
Cognitive Decline Minimal After Endocrine + CDK4/6 Inhibition in BCJuly 17, 2024Metastatic Breast CancerBreast CancerPatient & Survivor CareASCO Breast Cancer
Eribulin Similar to Taxane When Paired With Dual HER2 Blockade in BCJuly 10, 2024Breast CancerMetastatic Breast CancerPatient & Survivor CareASCO Breast Cancer
PFS Benefits Seen With Palbociclib + Endocrine Therapy in Breast CancerJuly 10, 2024Metastatic Breast CancerBreast CancerPatient & Survivor CareASCO Breast Cancer
New ADC results mixed in metastatic breast cancerJuly 8, 2024Metastatic Breast CancerBreast CancerPatient & Survivor CareASCO Breast Cancer
Adjuvant Avelumab Benefits Seen in High Risk, Triple Negative BCJuly 8, 2024Breast CancerPatient & Survivor CareASCO Breast Cancer
Platinum Add-On Improves Survival in Early TNBCJune 25, 2024Breast CancerPatient & Survivor CareASCO Breast Cancer
Inavolisib Added to Standard Tx Shows Sustained Benefit in Advanced BCJune 19, 2024Breast CancerPatient & Survivor CareASCO Breast Cancer
Surviving to Thriving: Enhancing Quality of Life in Breast CancerJune 17, 2024Breast CancerPatient & Survivor CareASCO Breast Cancer
T-DXd Moves Toward First Line for HER2-Low Metastatic BCJune 10, 2024Metastatic Breast CancerBreast CancerPatient & Survivor CareASCO Breast Cancer
Anti-Müllerian Hormone Predicts Chemo Benefits in BCJune 6, 2024Breast CancerPatient & Survivor CareASCO Breast Cancer
